ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 75 filers reported holding ARCELLX INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,352,000 | +100.6% | 400,000 | +76.8% | 4.04% | +61.5% |
| Q2 2023 | $7,154,816 | +14.5% | 226,275 | +11.6% | 2.50% | +21.2% |
| Q1 2023 | $6,249,316 | -16.0% | 202,834 | -15.5% | 2.06% | -29.3% |
| Q4 2022 | $7,439,630 | +88.6% | 240,143 | +14.3% | 2.92% | +165.0% |
| Q3 2022 | $3,944,000 | +190.9% | 210,138 | +180.2% | 1.10% | +92.5% |
| Q2 2022 | $1,356,000 | – | 75,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $170,390,217 | 62.20% |
| PATHWAY CAPITAL MANAGEMENT, LP | 189,120 | $5,858,938 | 10.46% |
| NEA Management Company, LLC | 4,745,262 | $147,008,217 | 8.26% |
| Samsara BioCapital, LLC | 957,451 | $29,661,832 | 6.38% |
| Soleus Capital Management, L.P. | 1,102,447 | $34,153,808 | 4.90% |
| Cormorant Asset Management, LP | 2,075,000 | $64,284 | 4.30% |
| Paradigm Biocapital Advisors LP | 882,101 | $27,327,489 | 3.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,350,333 | $72,813,316 | 3.06% |
| Affinity Asset Advisors, LLC | 240,143 | $7,439,630 | 2.92% |
| CAXTON CORP | 36,302 | $1,124,640 | 2.87% |